Valneva announces lifting of european medicines agency's temporary restriction on use of chikungunya vaccine ixchiq® in elderly

Saint herblain (france), july, 11 2025 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that the european medicines agency (ema) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of valneva's single-dose chikungunya vaccine ixchiq® by ema's safety committee (prac). the committee initiated its review at the beginning of may following the occurrence of serious side effects mainly in elderly people with several underlying medical conditions.
VALN Ratings Summary
VALN Quant Ranking